Cost-utility of First-line Disease-modifying Treatments for Relapsing–Remitting Multiple Sclerosis

201733 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Clinical Therapeutics

Volume 39, Issue 3, pp. 537-557.e10

Field-Weighted Citation Impact: 3.47